In an embodiment is provided a process to re-refine used oil that includes introducing a used oil and a solvent to a separation unit under separation conditions selected to produce a purified oil product, the separation unit comprising a porous membrane, a semiporous membrane, or both; and separating the used oil to obtain an effluent comprising a purified oil product. In another embodiment is provided an apparatus for re-refining used oil that includes a separation unit comprising a porous or semiporous membrane; a used oil feed coupled to an inlet of the separation unit; and an inlet of a diffusate collection unit coupled to an outlet of the separation unit. In another embodiment is provided a composition generated from a membrane separation process that includes a base oil, the composition having a soot content of about 0.05% or less.

A system for membrane fouling control configured to run one or more filter cycles, wherein each filter cycle of the one or more filter cycles includes an operation mode and a cleaning mode. The system includes: a first conduct portion; a second conduct portion; a membrane arranged between the first conduct portion and the second conduct portion. The membrane is configured in the operation mode to filter a liquid to be filtered by conducting it from the first conduct portion to the second conduct portion. A fouling control means filled with fouling control particles is added in the operation mode in the first conduct portion so that a dynamic protective layer is formed on the membrane. The fouling control particles are mineral particles based on calcium and/or magnesium.

The present invention in its broadest aspect relates to a method for reducing glycoalkaloid content and turbidity of an aqueous phase comprising compounds selected from two or more of PA, PI, PPO, LipO, pectin, lipid, glycoalkaloid and phenolic compounds of which at least one compound is selected from PA, PT, LipO and PPO; a) providing an aqueous phase comprising compounds selected from two or more of PA, PI, PPO, LipO, pectin, lipid, glycoalkaloid and phenolic compounds of which at least one compound is selected from PA, PT, LipO and PPO; and b) performing one or more steps to reduce the concentration of solanine in the dry matter of the aqueous phase with at least 15 percent, such as at least 20%, such as at least 25% and to achieve an optical density at 620 nm of the remaining aqueous phase of less than 0.7; such as less than 0.5; such as less than 0.3; such as less than 0.2; such as less than 0.1; and thereby obtaining an aqueous phase having reduced glycoalkaloid content and turbidity compared to an untreated aqueous phase.

Described herein is a method of using hollow fiber filter cartridge. The method includes: providing a hollow fiber filter cartridge inside or outside an environmental cleaning equipment; allowing a wastewater to enter the hollow fiber filter cartridge from an outside of the hollow fiber filter under no water pressure or low water pressure (such as under 30 gw/cm.sup.2); allowing the wastewater to cross a plurality of nanopores of the hollow fiber filter cartridge under no water pressure or low water pressure (such as under 30 gw/cm.sup.2) to produce a clean water; and allowing the environmental cleaning equipment to filter wastewater to produce clean water continuously, thereby improving cleaning efficiency and reducing water consumption.

A near-zero maintenance integrated purification device for drinking water supply of villages and towns and a method for treating source water using this device are provided to solve the multi-pollution problems caused by microorganisms, turbidity, iron, manganese, taste and odor, and organic matter in the drinking water sources of villages and towns. The device includes a small-spacing folding plate speed sink regulating water tank, a small diameter tube reactor, a granular active carbon (GAC) slow-speed filter tank, a gravity-driven ultrafiltration membrane tank and an ipsilateral U-turn corridor clean water tank. The near-zero maintenance integrated purification device is applicable to different types of water sources (e.g., groundwater, lake water, reservoir water, spring water, snowmelt water, cellar water and rain water, etc.), and could efficiently remove kinds of pollutants, improving the biological and chemical safety of drinking water.

A process for recovery and purification of HMOs comprising: (a) providing an HMO-containing fermentation broth comprising biomass; (b) separating the fermentation broth to form a separated HMO-containing stream and a biomass waste stream; (c) purifying the separated HMO-containing stream; (d) concentrating the separated HMO-containing stream; and (e) drying the product of steps (a)-(d) by an indirect drying method thereby forming a purified HMO, wherein steps (c)-(d) can be performed in any order.

The present disclosure provides the synthesis of an imidazolium-based functional ionic liquid copolymer (PMMA-b-PIL-R*) and a preparation method of an alloy ultra-filtration membrane. Firstly, PMMA-b-PIL-R* is prepared from methyl methacrylate (MMA) and polymerizable imidazolium-based functional ionic liquid (IL-R*) containing double bonding as the reactive monomers through sequential radical polymerization. With the use of a non-solvent induced phase separation method, PMMA-b-PIL-R* is introduced into the body of a polymeric membrane material, so as to prepare an alloy ultra-filtration membrane. A hydrogen-bond interaction is generated between the carbonyl in the molecular chain of PMMA-b-PIL-R* and the H . . . C—Cl structure in the molecular chain of the polymeric membrane material, which enhances the compatibility between the molecular chains of PMMA-b-PIL-R* and the polymeric membrane material, so that it can be stable in the ultra-filtration membrane; the imidazole groups and functional groups in the molecular chain of PMMA-b-PIL-R* can provide a good hydrophilicity.

The present invention provides novel and stable pharmaceutical compositions comprising bispecific single chain antibody constructs, cyclodextrins and a buffer.

The present disclosure relates to a new use of a tangential flow filtration device and a continuous concentration system for producing an ultra-high concentration medical exosome solution.

The present invention relates to an organic solvent-soluble copolymerized polyester, a composition for forming an ultrafiltration membrane including the same, and a high water-permeability reverse osmosis membrane prepared therefrom. More specifically, the present invention relates to a polyester that has a high solubility in organic solvents at room temperature and thus can be used to produce ultrafiltration membranes at low cost, a composition for forming an ultrafiltration membrane including the same, and a high water-permeability reverse osmosis membrane prepared therefrom, wherein the reverse osmosis membrane has a reduced production cost and high water permeability.